(Circulation. 1997;96:1192-1200.)
© 1997 American Heart Association, Inc.
Articles |
Adenosine-Sensitive Ventricular Tachycardia
Right Ventricular Abnormalities Delineated by Magnetic Resonance Imaging
From the Department of Medicine, Division of Cardiology, and the Department of Radiology, The New York Hospital–Cornell University Medical Center, New York, NY.
Correspondence to Bruce B. Lerman, MD, Division of Cardiology, Starr 4, The New York Hospital–Cornell Medical Center, 525 E 68th St, New York, NY 10021. E-mail blerman{at}mail.med.cornell.edu
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Background Adenosine-sensitive ventricular tachycardia (VT) is thought to be due to cAMP-mediated triggered activity. It typically originates from the RVOT and occurs in patients with apparently normal hearts. Using magnetic resonance imaging (MRI), we tested the hypothesis that adenosine-sensitive VT occurs in patients without structural heart disease.
Methods and Results Fourteen patients (9 women; age, 47±19 years) presented with sustained VT (n=3), repetitive monomorphic VT (n=7), or both (n=4). VT terminated with adenosine in each patient and was sensitive to vagal maneuvers in 9 of 11 and verapamil in 10 of 12. VT originated from the right ventricular outflow tract in 10 patients, the right ventricular apex in 1, and the left ventricular septum in 3. Conventional studies included normal signal-averaged ECGs in 9 of 9, normal right ventricular echocardiography in 10 of 10, and normal left ventriculography and coronary angiography in 6 of 7. In contrast, MRI scans were abnormal in 10 of 14 patients. These abnormalities included focal thinning (6), fatty infiltration (4), and wall motion abnormalities (4) of the right ventricle. The most common site of MRI abnormalities was the right ventricular free wall, but there was a poor correlation between the site of MRI abnormalities and the origin of VT. Among 18 control patients without clinical heart disease, thinning of the right ventricular wall was noted in only 1 patient (patients versus control subjects, P=.0001).
Conclusions Patients with idiopathic adenosine-sensitive VT comprise a heterogeneous group as assessed by MRI, with 70% demonstrating mild structural abnormalities. However, it is unlikely that these findings are causally related to tachycardia, and the functional significance of these anatomic abnormalities is uncertain.
Key Words: imaging • tachycardia • ventricles
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Idiopathic VT is defined as a ventricular arrhythmia that occurs in the absence of structural heart disease and is thought to be a "primary electrical disease." This characterization has relied on conventional imaging and diagnostic modalities, such as echocardiography, exercise stress testing, and coronary angiography.1 2 3 4 5 6 7 Subsequent analyses of patients with VT in the absence of clinically evident heart disease have used endomyocardial biopsy, signal-averaged ECG, and MRI to define previously undetected abnormalities.3 8 9 10 11 12 13 14 15 16 17 18 19 These reports have yielded conflicting results due to the heterogeneous nature of the populations studied with respect to the mechanisms of arrhythmogenesis.
The most common form of idiopathic VT originates from the RVOT and is associated with an LBBB, inferior axis morphology.1 4 7 10 12 13 14 15 20 21 22 23 24 Although multiple mechanisms may be responsible for tachycardia originating in this region, including reentry and automaticity, the most common and completely described subtypes are due to triggered activity arising from delayed afterdepolarizations, which are dependent on cAMP and intracellular calcium overload.20 21 22 25 These subtypes of idiopathic VT include exercise or stress-induced sustained VT and nonsustained RMVT. These forms of VT are facilitated by catecholamines and characteristically terminate with adenosine as well as vagal maneuvers, ß-blockers, and verapamil.
The primary defect in adenosine-sensitive VT has not been defined. Potential defects may reside at the molecular and cellular level (ie, in the ß-adrenergic signal transduction cascade) or at the level of myocardial innervation (ie, denervation hypersensitivity). Alternatively, the arrhythmia may be due to a subtle structural abnormality in the RV. Echocardiography and cardiac catheterization have limited sensitivity in detecting abnormalities in RV structure and function, and MRI with cine wall motion analysis has emerged as a more sensitive modality for imaging the RV.18 In this study, we used MRI to screen a homogeneous population of patients with idiopathic adenosine-sensitive VT for abnormalities in RV structure and function.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Patient Population
Patients and a control study group were enrolled in a protocol approved by the Institutional Review Board at the New York Hospital–Cornell Medical Center. The study population consisted of 14 patients with adenosine-sensitive VT (9 women; mean age at the time of presentation, 47±19 years; age range, 6 to 75 years). Clinical characteristics of patients are presented in Table 1
. Three patients presented with
paroxysmal sustained VT and 11 presented with RMVT, four of
whom also had at least one documented episode of sustained VT. Patients
with RMVT were characterized by frequent ventricular
extrasystoles, ventricular couplets, and recurrent runs of
nonsustained VT (3 to 30 beats) with intervening sinus rhythm. The
presenting symptoms were palpitations (12), presyncope or syncope
(7), and chest pain (3); one patient was asymptomatic. The
duration of symptoms was 58±131 months before the index
electrophysiological study. Eight of these
patients have been previously described (patients 2, 4 to 7, and 9 to
11) in a series of patients with RMVT.22 The control
population consisted of 18 age- and sex-matched volunteers (12 women;
mean age, 46±16 years; age range, 6 to 59 years) with no clinical
history of heart disease as assessed by questionnaire.
|
Electrophysiological Study and Ablation
Protocol
Electrophysiological studies were performed
after discontinuation of all antiarrhythmic agents for at least five
half-lives. Three quadripolar electrode catheters were inserted
percutaneously and advanced under fluoroscopic guidance
to the high right atrium, RV apex, and AV junction for
recording of the His bundle electrogram. In addition, a
quadripolar mapping catheter was introduced into the RV or left
ventricle after induction of VT. Bipolar intracardiac
recordings were filtered at 30 to 500 Hz and displayed
simultaneously with three surface ECG leads on a
multichannel oscilloscope or digital monitor. Data were stored on
magnetic tape or optical disk (Prucka Engineering). Systemic
arterial pressure was continuously monitored (Dinamap,
Critikon). Stimulation was performed with a programmable stimulator and
an isolated constant current source (Bloom Associates), and stimuli
were delivered as rectangular pulses of 2-ms duration at four times
diastolic threshold. The stimulation protocol included the
introduction of single, double, and triple extrastimuli during several
paced cycle lengths and rapid burst pacing from multiple atrial and
ventricular sites. In addition, the ability of
isoproterenol (2 to 10 µg/min) to initiate VT either alone or during
concurrent pacing was evaluated.
Inclusion in this study required that patients have inducible sustained
VT at electrophysiological study that
terminated with adenosine (100 to 475 µg/kg IV) given as a
rapid bolus followed by a saline flush or incessant nonsustained
monomorphic VT that was suppressed with a comparable dose of
adenosine. In addition, the following pharmacological
sensitivities were tested: (1) edrophonium, given as a 1-mg IV test
dose followed by 9 mg IV over 1 minute, (2) esmolol, one or two boluses
of 500 µg/kg IV over 1 min followed by an infusion of 50 to 100
µg/kg/min; or 0.1 mg/kg propranolol IV over 5 minutes,
and (3) 10 to 15 mg verapamil IV infused over 1 minute.
Vagal maneuvers such as Valsalva and carotid sinus massage were also
evaluated. Sensitivity of nonsustained VT to these pharmacological
interventions was defined as the absence of ventricular
ectopy for a specified time after intervention, with recurrent
ventricular couplets and runs of nonsustained VT in the 60
seconds preceding a perturbation. In the cases of adenosine and
vagal maneuvers, suppression of ectopy was required for 
10 seconds
after intervention. Comparable times were 1 minute after
administration of edrophonium and 5 minutes after infusion of
verapamil. Noninducibility of VT by programmed stimulation
after administration of verapamil was also regarded as
evidence for suppression if VT was reproducibly induced before
intervention.
Detailed activation and pace mapping were performed in 12 patients to identify the focal origin of VT and guide ablation. An adequate pace map was defined as a match of 11 or 12 surface leads during pacing at the tachycardia cycle length. If an adequate pace map was not obtained in the RV, pace mapping was performed in the left ventricular outflow tract via a retrograde approach. In the remaining 2 patients, the origin of VT was inferred from the morphology of VT on the surface ECG.
Radiofrequency ablation was performed in 11 patients with current
generated by a conventional 500-kHz radiofrequency energy source
(EPT-1000, EP Technologies or Radionics) delivered from the 4-mm tip of
a steerable mapping catheter (EPT Steerocath-T, EP Technologies or
Mansfield EP) to a left subscapular chest wall patch (7.25x1.5 in).
Energy was applied at 10 to 50 W for 
60 seconds to obtain a tip
temperature of 60° (where monitored) or until an abrupt rise occurred
in catheter impedance. DC ablation was performed in 1 patient. After
positioning of the mapping catheter (6F quadripolar, Bard
Electrophysiology) at the site of an appropriate pace map, two DC
shocks of 200 J each were delivered via a conventional defibrillator
(Zoll) to a subscapular patch. Successful ablation was defined by the
absence of spontaneous and inducible VT 30 minutes after the
procedure.
Signal-Averaged ECG
Signal averaging was performed using standard bipolar X, Y, and
Z leads and a high-pass filter of 40 Hz (Predictor, Corazonix Inc).
Beats were averaged to obtain a noise level of 0.3 µV. The filtered
QRS vector was analyzed for QRS duration (normal <114 ms), RMS
voltage of the terminal 40 ms of the QRS (normal >20 µV), and the
duration of the LAS <40 µV (normal <38 ms). The signal-averaged ECG
was regarded as abnormal if the filtered QRS duration was prolonged and
terminal RMS voltage, LAS duration, or both were abnormal.
MRI
All patients and control subjects underwent an identical MRI
protocol. The MRI imaging study was conducted a mean of 26±22 months
after the initial electrophysiological
study. In patients who underwent ablation, MRI was performed a mean of
21±16 months (range, 1 day to 58 months) after ablation; in 1 patient,
MRI was performed 1 day before
electrophysiological study and ablation. In
the 2 patients who did not have ablation, MRI was performed 19 and 57
months after the initial electrophysiological study.
MRI studies were performed on a General Electric Signa 1.5-T system. All scans were regular spin echo sequences, which were gated to the R wave of the ECG. Respiratory compensation was also applied to minimize breathing artifact. The following sequences were used to obtain static images: T1-weighted coronal, T1-weighted axial, T2-weighted axial, and T1-weighted axial with a saturation pulse placed posterior to the interventricular septum. The repetition time (TR) was determined by the RR interval, and the echo time (TE) was 20 ms. Slice thickness was 5.0 mm with an interslice spacing of 1.5 mm. Data were collected using a 256x128 matrix with two data acquisitions and a field of view of 32 to 40 cm depending on patient size and habitus.
Cine images were obtained using cardiac-gated gradient echo pulse sequences with flow compensation to increase the contrast of flowing blood. Contiguous 10-mm axial sections were obtained from above the pulmonary artery to below the diaphragmatic walls of the heart. For each axial section, 16 frames were obtained, equally spaced within the RR interval. Each set of images for a given axial section was played sequentially in a cine mode to visualize wall motion and flow abnormalities. In two subjects (patient 13 and a 6-year-old male control subject), cine images were not obtained due to inability to tolerate the complete protocol, and the evaluation was limited to static images.
Each study was separately interpreted by three radiologists who were blinded to the patient's clinical status and examined for abnormalities of the morphology of the RV free wall, RVOT, and left ventricle. High-intensity lesions on T1-weighted images were interpreted as fatty deposition. Fatty infiltration was defined only if the observed abnormality was intramyocardial; signal intensity from the region of fatty infiltration was compared with neighboring subepicardial muscle, and an abnormality was defined only if intervening epicardial tissue was devoid of fat. Contiguous slices were examined to confirm that tissue surrounding the deposit was free of fatty infiltration. Measurements of RV wall thickness were performed on spin echo images obtained during systole. Images were synchronized with R wave of the ECG with a delay of 150 ms; all images from the region of the heart were obtained within 80 ms of the earliest slice. Measurements of wall thickness refer to the anterior RV free wall, which is defined as the wall between the RV apex and the tricuspid annulus, as imaged in axial sections. Focal thinning of the RV free wall was defined as a wall thickness of <2 mm, with the abnormal region thinner than neighboring segments. Cine studies were evaluated separately from the static images and studied for irregularities in wall motion and wall thickening in each of the chambers, as well as irregular blood flow patterns. Focal hypokinesis and dyskinesis were defined, respectively, as decreased systolic excursion and paradoxical motion of an RV wall segment compared with neighboring segments, as assessed visually. Abnormalities were defined if observed by two of the three observers.
Statistical Analysis
Results are presented as mean±SD where appropriate.
Comparisons between groups were performed with the Fisher exact test,
the two-tailed t test for independent groups, and the
Mann-Whitney test for nonparametric variables. A value
of P<.05 was required to reject the null hypothesis.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Electrophysiological Findings
At electrophysiological study, a single morphology of VT was induced in 13 patients, demonstrating an LBBB morphology in 11 (inferior axis in 10, superior axis in 1) and an RBBB morphology in 2 (inferior axis in 1, superior axis in 1). In 1 patient (patient 2), two morphologies of VT were induced: LBBB, inferior axis; and RBBB, inferior axis with identical cycle lengths.
VT could be induced with programmed stimulation in 12 patients and was
present incessantly in 2 patients. Sustained VT (>30 beats) was
induced in 11 patients, and adenosine reproducibly terminated
sustained VT in each patient (Fig 1). Repetitive runs of
nonsustained VT were present in the remaining 3 patients and could
be induced with programmed stimulation in 1; adenosine
suppressed ventricular ectopy in each of these patients.
Facilitation of VT induction with isoproterenol was demonstrated in 12
patients. VT terminated with vagal maneuvers or edrophonium in 9 of 11
patients, and the arrhythmia terminated or was rendered
noninducible after administration of verapamil in 10 of 12
patients (Table 2).
|
|
VT originated from the RVOT in 10 patients, the RV apex in 1, and the
left ventricular septum in 3. Of 10 patients with an LBBB,
inferior axis VT morphology, pace mapping localized the
arrhythmogenic focus to the RV outflow tract in 7. In 1 patient
demonstrating VT with an LBBB, inferior axis morphology
(patient 11), adequate pace maps were obtained in the RVOT, and
radiofrequency ablation was performed in this region. After the
recurrence of tachycardia with a similar morphology
1 year later, pace mapping localized the tachycardia to the
left ventricular septum, where successful ablation was
performed (Figs 2 and 3). Two patients
with an LBBB, inferior axis morphology, did not undergo
detailed mapping, and the site of origin was inferred to be the RVOT
(patients 3 and 9). In the 1 patient demonstrating VT with an LBBB,
superior axis, an exact pace map was obtained at the RV apex. In the 2
patients demonstrating VT with an RBBB, pace mapping localized the
arrhythmogenic foci to the superior septal region of the left
ventricle.
|
|
Radiofrequency ablation was performed in 11 patients (mean, 14±8 applications of radiofrequency energy), and DC ablation was performed in 1 patient (patient 2). The 2 patients not undergoing ablation have been maintained on verapamil with clinical improvement.
Conventional Assessment for Structural Heart Disease
Surface ECGs were normal in 12 patients. One patient demonstrated
left ventricular hypertrophy (patient 1), and
one demonstrated an RV conduction delay (patient 6). Signal-averaged
ECGs demonstrated no evidence for late potentials in 9 of 9 patients.
Echocardiography demonstrated normal RV
architecture in 10 of 10 patients; mild left-sided valvular
abnormalities (mitral valve prolapse, mild mitral and aortic
regurgitation) were noted in 4 patients. Left
ventriculography and coronary angiography were normal in 6 of
7; 1 patient demonstrated a moderate (50%) stenosis of the mid
left anterior descending coronary artery.
In 1 patient who presented with repetitive monomorphic VT
demonstrating an LBBB, left inferior axis morphology
(patient 6), considerable lability was evident on the surface ECG
during sinus rhythm. On presentation, an RV conduction
delay with normal anterolateral T waves was present (Fig 4A); 3 days later, anterolateral T-wave inversions were
evident (Fig 4B). A treadmill test was normal (96% maximal predicted
heart rate), and echocardiography was normal. Pace
mapping identified the arrhythmogenic focus in the RVOT (Fig 5), and successful ablation was performed at this site
(Fig 6).
|
|
|
MRI
MRI scans in 17 of 18 control subjects demonstrated no
abnormalities of ventricular structure or function. In 1
control 6-year-old boy, the MRI demonstrated mild thinning of the RV
free wall on static spin echo images, but no wall motion abnormalities
were detected on cine images. In contrast, 10 of 14 patients with
adenosine-sensitive VT demonstrated an abnormality by MRI
(patients versus control subjects, 71% versus 6%,
P=.0001). Six patients demonstrated focal thinning of the RV
free wall, defined as a localized region with wall thickness of
<2 mm. In contrast, RV wall thickness exceeded 2 mm in 17
control subjects. Fatty infiltration of the RV wall was demonstrated in
4 patients with VT, and wall motion abnormalities of the RV were
present in 4 (Table 3 and Figs 7 to 9). These abnormalities
were not present in control subjects. Left ventricular
hypertrophy and hypokinesis of the left
ventricular apex were each noted in 2 patients.
|
|
|
|
The most common site of MRI abnormalities was the RV free wall (9
patients), whereas only 3 patients demonstrated abnormalities in the
structure or function of the RVOT. There was a poor correlation between
the site of MRI abnormalities and the origin of VT defined by pace
mapping and VT morphology (Table 3
). Of 10 patients with an
arrhythmogenic focus that mapped to the RVOT, isolated focal
abnormalities were detected by MRI in the RV free wall in 5 and in the
RVOT in 1; 2 patients demonstrated abnormalities in both the RV free
wall and RVOT, and 2 were normal.
Fatty infiltration was noted in the RV free wall in 3 patients and in
the RVOT in 1 patient. In general, these were focal intramural lesions,
and diffuse transmural replacement with adipose tissue was not
observed. Two patients with focal adipose lesions in the RV free wall
also had associated thinning and focal hypokinesis of the free wall. In
patient 6, who presented with repetitive monomorphic VT
localizing to the RVOT and a surface ECG notable for an RV conduction
delay with anterior T-wave inversions, fatty infiltration with apical
thinning and focal hypokinesis were noted in the RV free wall (Fig 9).
The presence of MRI abnormalities did not correlate with age, clinical presentation (sustained VT versus RMVT), duration of symptoms, number of radiofrequency applications, or interval between ablation and MRI scanning. Abnormalities were detected in two patients who were not subject to ablation, including focal fatty infiltration in the RV free wall of a 7-year-old boy (patient 9) and focal thinning and dyskinesis in the RV free wall of a 46-year-old woman (patient 3). In both patients, the morphology of VT was LBBB inferior axis, which is consistent with an RVOT origin.
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
The major finding of this study is that despite similarities in electrophysiological properties, patients with idiopathic adenosine-sensitive VT comprise a heterogeneous population as assessed by MRI. Abnormalities in the RV, such as focal wall thinning, fatty infiltration, and regional wall motion abnormalities, were present in 71% of the patients studied, whereas only 1 control subject demonstrated thinning of the RV free wall (6%). These findings were present despite normal results obtained with conventional imaging. However, it is unlikely that the structural abnormalities identified by MRI are causally related to adenosine-sensitive VT because the location of these abnormalities did not correspond to the electrophysiologically defined VT origin and no abnormalities were observed in nearly 30% of patients.
Structural Abnormalities in Idiopathic VT
The definition of idiopathic VT is based on the absence of
structural heart disease and depends on the diagnostic
modalities used to assess cardiac structure. Previous studies have used
echocardiography, RV angiography,
endomyocardial biopsy, and the signal-averaged ECG
to demonstrate that a substantial minority of patients with RV
tachycardia have structural abnormalities in the
RV.2 3 5 7 In these studies, the response to
adenosine was not assessed, and it is likely that the
populations studied were heterogeneous with respect to the
tachycardia mechanism. For example, in a report of 10 patients
with VT arising from the RVOT, three presumptive mechanisms were
identified: reentry, automaticity, and triggered
activity.12 In contrast, studies in patients with
adenosine-sensitive VT have demonstrated no structural
abnormalities as defined by echocardiography,
angiography, signal-averaged ECG, and myocardial
biopsy.20 21 22 23
More recently, MRI has been used to detect subtle wall motion and structural abnormalities in the RV in patients with tachycardia arising from the RVOT.16 18 19 The results of these studies are inconsistent. For instance, a total of 16 patients with RVOT tachycardia had normal static MRI scans in previous series.13 14 15 In contrast, Carlson et al18 demonstrated focal wall thinning, excavation, and decreased systolic thickening in 95% of patients with VT originating from the RVOT, although RV function was normal as assessed by echocardiography. In their study, the most common site of abnormality was the RVOT, but they also observed abnormalities in the RV free wall and RV apex. Their findings differ from our data in several respects. In the present study, abnormalities clustered in the RV free wall rather than the RVOT, typically at sites remote from the tachycardia origin. In addition, we identified the presence of fatty infiltration, which has not been previously described in this population. A likely explanation for this discrepancy is that a variety of mechanisms may have been responsible for RVOT tachycardia in the previous study, whereas in the present study, a homogeneous group of patients were studied with respect to VT mechanism (ie, adenosine-sensitive triggered activity).
Significance of Abnormalities
Several explanations may account for the abnormal MRI results
defined in this study. One unexpected finding was focal fatty
deposition in 29% of patients, suggesting the possibility that
patients with adenosine-sensitive VT who manifest structural
abnormalities by MRI represent a forme fruste or an
unrecognized variant of ARVD. This latter entity is characterized by
fibroadipose replacement of myocardial tissue in the
RV,26 27 28 and MRI has emerged as an important
diagnostic modality in these patients. Characteristic MRI
abnormalities are considered to include diffuse transmural or focal
fatty deposition in the RV free wall and extreme thinning of the RV
wall, which may be focal or diffuse in nature.17 29 30 31 32
Patients with adenosine-sensitive VT and ARVD share several
other features in common; these include facilitation of
tachycardia by catecholamines or exercise and
an RV origin, which may result in an LBBB, inferior axis VT
morphology.26 Of interest, 1 patient who presented
with repetitive monomorphic VT demonstrated findings typical of ARVD on
the surface ECG (RV conduction delay with anterior T-wave inversions).
This patient was found to have fatty infiltration of the RV free wall
with wall thinning and focal dyskinesis, suggesting a link between
adenosine-sensitive VT and ARVD.
These two forms of VT, however, demonstrate important differences with respect to mechanism and prognosis. ARVD is thought to be due to a reentrant mechanism, which is supported by the high prevalence of late potentials detected by signal-averaged ECG33 34 and the consistent demonstration of entrainment.35 In contrast, patients with adenosine-sensitive VT share a mechanism of tachycardia consistent with triggered activity arising from delayed afterdepolarizations and inconsistent with reentry. This is supported by termination of tachycardia with adenosine as well as sensitivity to vagal maneuvers and calcium channel blockers.20 21 22 We have previously shown that adenosine demonstrates mechanism-specific effects in VT, in that reentrant tachycardia such as that observed in patients with clinically and pathologically defined ARVD is insensitive to adenosine.36 A focal mechanism of arrhythmogenesis in adenosine-sensitive VT is further supported by the absence of late potentials, a finding demonstrated in the present study and reported in previous series of patients with VT arising from RVOT.1 19 23 37 The success of radiofrequency ablation guided by pace mapping further underscores the focal nature of this tachycardia.12 24
Although there is a relative paucity of data regarding the effects of pharmacological probes on VT due to ARVD, results suggest that this form of VT is insensitive to adenosine, vagal maneuvers, verapamil, and ß-blockers. We reported 2 patients with ARVD, each of whom demonstrated catecholamine-facilitated reentry, in whom adenosine had no effect on ventricular tachycardia.36 Wichter et al47 demonstrated that verapamil and ß-blockers did not prevent inducibility of VT by programmed stimulation in 5 and 8 patients, respectively, with ARVD. Thus, adenosine-sensitive VT and ARVD likely represent different electrophysiological entities. The results of this study therefore call into question the specificity of fatty deposition and wall thinning in establishing the diagnosis of ARVD.17
A second possibility is that these structural abnormalities are a secondary response to recurrent tachycardia. Tachycardia-related cardiomyopathy has been demonstrated in patients with orthodromic AV reciprocating tachycardia, atrial tachyarrhythmias, and VT.38 39 40 41 42 In animal models of pacing-induced cardiomyopathy, short-term pathological changes include myocyte loss, reactive hypertrophy, and replacement fibrosis in the left ventricle43 44 ; however, fatty replacement has not been reported. Also inconsistent with this hypothesis is that tachycardia-related cardiomyopathy typically involves both ventricles, and one would thus expect to visualize structural abnormalities in both chambers. Finally, the duration of symptoms, clinical presentation (paroxysmal VT versus RMVT), and time since successful ablation did not predict the presence of MRI abnormalities in the present study.
A final explanation is that the structural changes are secondary to an underlying pathological process that results in triggered activity and that focal fat deposition and wall thinning are nonspecific responses to injury in the RV. The basic defect in adenosine-sensitive VT, whether on a cellular or neuronal level, is not yet defined. An abnormality resulting in extensive activation of any component of the ß-adrenergic signal transduction cascade could be responsible for provoking tachycardia in these patients. One such hypothetical example would be sympathetic denervation, which would result in catecholamine hypersensitivity and potentially lead to structural abnormalities in the RV.
Study Limitations
The interpretation of fatty infiltration in the RV is confounded
by the normal distribution of fat in the
atrioventricular groove and epicardial surface and the
introduction of factitious areas of high intensity on T1-weighted
images due to artifacts from the ventricular blood
pool.32 In addition, wall thinning may be difficult to
interpret due to normal thinning of the RV apex and the presence of
trabeculation in the RV. These technical limitations were
addressed by using a saturation pulse at the level of the
interventricular septum, thus minimizing T1 artifact from
the underlying blood pool and enhancing the resolution of the RV free
wall. Abnormal wall thickness was defined if the RV wall was <2
mm and thinner than neighboring segments, with confirmation from
saturation pulse images. In addition, fatty infiltration was defined
only if intense T1 signals were detected from within the myocardial
wall (Fig 9). The combination of fatty infiltration, wall thinning, and
wall motion abnormalities is suggestive of a pathological process. Of
importance, we observed no fatty deposition in 18 clinically normal
control subjects, which further supports the significance of these
findings.
A potential limitation is that the MRI abnormalities observed in these patients may be a secondary effect of ablation. Histological examination of chronic radiofrequency lesions in animal models and humans has demonstrated fibrosis, granulation tissue, and fat deposition.45 46 However, this explanation is unlikely to account for the structural abnormalities observed in this study because the sites identified by MRI did not correspond to the sites of ablation. Ablation was guided by pace mapping, and lesions were placed in a circumscribed region, remote from the subtricuspid free wall. Finally, the number of radiofrequency applications did not predict the presence of MRI abnormalities, and structural changes, including fat, were detected in 2 patients who did not undergo ablation.
Because MRI and other imaging modalities were not performed at the same time, we cannot compare the relative yields of each modality in detecting subtle anatomic abnormalities. In several patients, however, each test was obtained within a short time (patients 12 to 14), and MRI emerged as the most sensitive modality.
Clinical Implications
The findings of this study raise questions with regard to the
specificity of MRI-defined fatty deposition, wall thinning, and
abnormal wall motion in the diagnosis of ARVD. The functional
significance of these anatomic abnormalities remains uncertain,
particularly because nearly 30% of patients had no abnormalities
defined in this study. In addition, the prognostic implications of
these findings have yet to be established. It is unknown whether these
structural abnormalities will herald future sites of de novo
arrhythmias or if they will remain
physiologically unimportant. Serial MRI scans
will be important in addressing this question and defining the natural
history of adenosine-sensitive VT.
|
Selected Abbreviations and Acronyms |
|---|
|
|
Acknowledgments |
|---|
This work was supported in part by a grant from the National Institutes of Health (RO1-44747) and the Rosenfeld Heart Foundation. Dr Lerman is an Established Investigator of the American Heart Association.
Received September 30, 1996; revision received February 20, 1997; accepted March 11, 1997.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Buxton AE, Waxman HL, Marchlinski FE, Simson MD, Cassidy D, Josephson ME. Right ventricular tachycardia: clinical and electrophysiologic characteristics. Circulation. 1983;68:917-927.
2. Pietras RJ, Lam W, Bauernfeind R, Sheikh A, Palileo E, Strasberg B, Swiryn S, Rosen KM. Chronic recurrent right ventricular tachycardia in patients without ischemic heart disease: clinical, hemodynamic, and angiographic findings. Am Heart J. 1983;105:357-366.[Medline] [Order article via Infotrieve]
3.
Morgera T, Salvi A, Alberti E, Silvestri F, Camerini
F. Morphological findings in apparently idiopathic
ventricular tachycardia: an
echocardiographic, hemodynamic and
histologic study. Eur Heart J. 1985;6:323-334.
4.
Deal BJ, Miller SM, Scagliotti D, Prechel D,
Gallastegui JL, Hariman RJ. Ventricular
tachycardia in a young population without overt heart
disease. Circulation. 1986;73:1111-1118.
5.
Foale RA, Nihoyannopoulos P, Ribeiro P, McKenna WJ,
Oakley CM, Krikler DM, Rowland E. Right ventricular
abnormalities in ventricular tachycardia of
right ventricular origin: relation to electrophysiologic
abnormalities. Br Heart J. 1986;56:45-54.
6.
Lemery R, Brugada P, Bella PD, Dugernier T, van den
Dool A, Wellens HJJ. Nonischemic ventricular
tachycardia: clinical course and long-term follow-up in
patients without clinically overt heart disease.
Circulation. 1989;79:990-999.
7. Proclemer A, Ciani R, Feruglio GA. Right ventricular tachycardia with left bundle branch block and inferior axis morphology: clinical and arrhythmological characteristics in 15 patients. PACE. 1989;12:977-989.
8.
Strain JE, Gose RM, Factor SM, Fisher JD.
Results of endomyocardial biopsy in patients with
spontaneous ventricular tachycardia but without
apparent structural heart disease. Circulation. 1983;68:1171-1181.
9. Sugrue DD, Holmes DR, Gersh BJ, Edwards WD, McLaran CJ, Wood DL, Osborn MJ, Hammill SC. Cardiac histologic findings in patients with life-threatening ventricular arrhythmias of unknown origin. J Am Coll Cardiol. 1984;4:952-957.[Abstract]
10. Mehta D, Odawara H, Ward DE, McKenna WJ, Davies MJ, Camm AJ. Echocardiographic and histologic evaluation of the right ventricle in ventricular tachycardias of left bundle branch block morphology without overt cardiac abnormality. Am J Cardiol. 1989;63:939-944.[Medline] [Order article via Infotrieve]
11. Mehta D, McKenna WJ, Ward DE, Davies MJ, Camm AJ. Significance of signal-averaged electrocardiography in relation to endomyocardial biopsy and ventricular stimulation in patients with ventricular tachycardia without clinically apparent heart disease. J Am Coll Cardiol. 1989;14:372-379.[Abstract]
12.
Morady F, Kadish AH, DiCarlo L, Kou WH, Winston S,
deBuitlier M, Calkins H, Rosenheck S, Sousa J. Long-term results
of catheter ablation of idiopathic right ventricular
tachycardia. Circulation. 1990;82:2093-2099.
13. Coggins DL, Lee RJ, Sweeney J, Chein WW, Van Hare G, Epstein L, Gonzalez R, Griffin JC, Lesh M, Scheinman MM. Radiofrequency catheter ablation as a cure for idiopathic tachycardia of both left and right ventricular origin. J Am Coll Cardiol. 1994;23:1333-1341.[Abstract]
14. O'Connor BK, Case CL, Sokoloski MC, Blair H, Cooper K, Gillette PC. Radiofrequency catheter ablation of right ventricular outflow tachycardia in children and adolescents. J Am Coll Cardiol. 1996;27:869-874.[Abstract]
15. Movsowitz C, Schwartzman D, Callans DJ, Preminger M, Zado E, Gottlieb CD, Marchlinski FE. Idiopathic right ventricular outflow tract tachycardia: narrowing the anatomic location for successful ablation. Am Heart J. 1996;131:930-936.[Medline] [Order article via Infotrieve]
16. Gill JS, Rowland E, de Belder M, Morgado F, Rees S, Ward DE, Underwood R, Camm AJ. Cardiac abnormalities not visualised by echocardiography and angiography are detected by magnetic resonance imaging in patients with idiopathic ventricular tachycardia. Eur Heart J. 1993;14:7A. Abstract.
17. Blake LM, Abbot JA, Alla SR, Higgins CB, Scheinman MM. Sensitivity and specificity of MRI for the diagnosis of right ventricular dysplasia versus right ventricular outflow tract tachycardia. Circulation. 1994;90(suppl I):I-300. Abstract.
18. Carlson MD, White RD, Throhman RG, Adler LP, Biblio LA, Merkatz KA, Waldo AL. Right ventricular outflow tract ventricular tachycardia: detection of previously unrecognized anatomic abnormalities using cine magnetic resonance imaging. J Am Coll Cardiol. 1994;24:720-727.[Abstract]
19. Grimm W, Hoffman J, Michalik-Himmelmann R, Maisch B. Magnetic resonance imaging and signal averaged ECG in patients with repetitive monomorphic ventricular tachycardia and otherwise normal electrocardiogram. PACE. 1995;18:924. Abstract.
20.
Lerman BB, Belardinelli L, West GA, Berne RM, DiMarco
JP. Adenosine-sensitive ventricular
tachycardia: evidence suggesting cyclic AMP-mediated
triggered activity. Circulation. 1986;74:270-280.
21.
Lerman BB. Response of nonreentrant
catecholamine-mediated ventricular
tachycardia to endogenous adenosine and
acetylcholine: evidence for myocardial receptor-mediated
effects. Circulation. 1993;87:382-390.
22.
Lerman BB, Stein KM, Engelstein ED, Battleman DS,
Lippman N, Bei D, Catanzaro D. Mechanism of repetitive
monomorphic ventricular tachycardia.
Circulation. 1995;92:421-429.
23.
Wilber DJ, Baerman J, Olshansky B, Kall J, Koop
D. Adenosine-sensitive ventricular
tachycardia: clinical characteristics and response to
catheter ablation. Circulation. 1993;87:126-134.
24.
Klein LS, Shih HT, Hackett FK, Zipes DP, Miles
WM. Radiofrequency catheter ablation of ventricular
tachycardia in patients without structural heart
disease. Circulation. 1992;85:1666-1674.
25.
Lerman BB, Belardinelli L. Cardiac
electrophysiology of adenosine: basic and clinical
concepts. Circulation. 1991;83:1499-1509.
26.
Marcus FI, Fontaine GH, Guiraudon G, Frank R,
Laurenceau JL, Malergue C, Grosgogeat Y. Right
ventricular dysplasia: a report of 24 adult cases.
Circulation. 1982;65:384-398.
27. Thiene G, Nava A, Corrado D, Rossi L, Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med. 1988;318:129-133.[Abstract]
28. Marcus FI, Fontaine G. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: a review. PACE. 1995;18:1298-1314.
29. Casolo GC, Poggesi L, Boddi M, Fazi A, Bartolozzi C, Lizzadro G, Dabizzi RP. ECG-gated magnetic resonance imaging in right ventricular dysplasia. Am Heart J. 1987;113:1245-1248.[Medline] [Order article via Infotrieve]
30. Ricci C, Longo R, Pagnan L, Dalla Palma L, Pinamonti B, Camerini F, Bussani R, Silvestri F. Magnetic resonance imaging in right ventricular dysplasia. Am J Cardiol. 1992;70:1589-1595.[Medline] [Order article via Infotrieve]
31.
Auffermann W, Wichter T, Breithardt G, Joachimsen K,
Peters PE. Arrhythmogenic right ventricular disease:
MR imaging vs angiography. Am J Radiol. 1993;161:549-555.
32.
Blake LM, Scheinman MM, Higgins CB. MR features
of arrhythmic right ventricular dysplasia.
Am J Radiol. 1994;162:809-812.
33.
Kinoshita O, Fontaine G, Rosas F, Elias J, Iwa T, Tonet
J, Lascault G, Frank R. Time- and frequency-domain
analyses of the signal-averaged ECG in patients with
arrhythmogenic right ventricular dysplasia.
Circulation. 1995;91:715-721.
34. Oselladore L, Nava A, Buja G, Turrini P, Daliento L, Livolsi B, Thiene G. Signal-averaged electrocardiography in familial form of arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol. 1995;75:1038-1041.[Medline] [Order article via Infotrieve]
35. Aizawa Y, Funazaki T, Takahashi M, Naitoh N, Miyajima T, Kusano Y, Shibata A, Misaki T. Entrainment of ventricular tachycardia in arrhythmogenic right ventricular tachycardia. PACE. 1991;14:1606-1613.
36. Lerman BB, Stein KM, Markowitz SM. Is the response of catecholamine-dependent ventricular tachycardia to adenosine mechanism specific? J Am Coll Cardiol. 1996;27:24A. Abstract.
37. Mont L, Seixas T, Brugada P, Brugada J, Simonis F, Kriek E, Smeets JLRM, Wellens HJJ. The electrocardiographic, clinical, and electrophysiologic spectrum of idiopathic ventricular tachycardia. Am Heart J. 1992;124:746-753.[Medline] [Order article via Infotrieve]
38.
McLaran CJ, Gersh BJ, Sugrue DD, Hammill SC, Seward JB,
Holmes DR. Tachycardia induced myocardial
dysfunction: a reversible phenomenon? Br Heart
J. 1985;53:323-327.
39. Packer DL, Bardy GH, Worley SJ, Smith MS, Cobb FR, Coleman RE, Gallagher JJ, German LD. Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction. Am J Cardiol. 1986;57:563-570.[Medline] [Order article via Infotrieve]
40. Rakovec P, Lajovic J, Dolenc M. Reversible congestive cardiomyopathy due to chronic ventricular tachycardia. PACE. 1989;12:542-545.
41. Cruz FE, Cheriex EC, Smeets JL, Atie J, Peres AK, Penn OC, Brugada P, Wellens HJ. Reversibility of tachycardia-induced cardiomyopathy after cure of incessant supraventricular tachycardia. J Am Coll Cardiol. 1990;16:734-744.
42. Grogan M, Smith HC, Gersh BJ, Wood DL. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol. 1992;69:1570-1573.[Medline] [Order article via Infotrieve]
43. Tanaka R, Spinale FG, Zile MR, Crawford FA. Left ventricular function and morphological changes with supraventricular tachycardia in newborn swine. J Am Coll Cardiol. 1992;20:1650-1660.[Abstract]
44.
Kajstura J, Zhing X, Liu Y, Szoke E, Cheng W, Olivetti
G, Hintze TH, Anversa P. The cellular basis of pacing-induced
cardiomyopathy: myocyte cell loss and myocyte
cellular reactive hypertrophy.
Circulation. 1995;92:2306-2317.
45. Huang SK, Bharati S, Lev M, Marcus FI. Electrophysiologic and histologic observations of chronic atrioventricular block induced by closed-chest catheter desiccation with radiofrequency energy. PACE. 1987;10:805-816.
46. Huang SK, Bharati S, Graham AR, Lev M, Marcus FI, Odell RC. Closed chest catheter desiccation of the atrioventricular junction using radiofrequency energy: a new method of catheter ablation. J Am Coll Cardiol. 1987;9:349-358.[Abstract]
47.
Wichter T, Borggrefe M, Haverkamp W, Chen X, Breithardt
G. Efficacy of antiarrhythmic drugs in patients with
arrhythmogenic right ventricular disease: results in
patients with inducible and noninducible ventricular
tachycardia. Circulation. 1992;86:29-37.
This article has been cited by other articles:
 |
|
 |
|
  D. Corrado, C. Basso, L. Leoni, B. Tokajuk, P. Turrini, B. Bauce, F. Migliore, A. Pavei, G. Tarantini, M. Napodano, et al. Three-Dimensional Electroanatomical Voltage Mapping and Histologic Evaluation of Myocardial Substrate in Right Ventricular Outflow Tract Tachycardia. J. Am. Coll. Cardiol., February 19, 2008; 51(7): 731 - 739. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Timmermans, L.-M. Rodriguez, H. J.G.M. Crijns, A. F.M. Moorman, and H. J.J. Wellens Idiopathic Left Bundle-Branch Block-Shaped Ventricular Tachycardia May Originate Above the Pulmonary Valve Circulation, October 21, 2003; 108(16): 1960 - 1967. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. O'Donnell, D. Cox, J. Bourke, L. Mitchell, and S. Furniss Clinical and electrophysiological differences between patients with arrhythmogenic right ventricular dysplasia and right ventricular outflow tract tachycardia Eur. Heart J., May 1, 2003; 24(9): 801 - 810. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. W. M. Kayser, E. E. van der Wall, M. U. Sivananthan, S. Plein, T. N. Bloomer, and A. de Roos Diagnosis of Arrhythmogenic Right Ventricular Dysplasia: A Review RadioGraphics, May 1, 2002; 22(3): 639 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F Niroomand, C Carbucicchio, C Tondo, S Riva, G Fassini, A Apostolo, N Trevisi, and P Della Bella Electrophysiological characteristics and outcome in patients with idiopathic right ventricular arrhythmia compared with arrhythmogenic right ventricular dysplasia Heart, January 1, 2002; 87(1): 41 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ahmad, D. Li, A. Karibe, O. Gonzalez, T. Tapscott, R. Hill, D. Weilbaecher, P. Blackie, M. Furey, M. Gardner, et al. Localization of a Gene Responsible for Arrhythmogenic Right Ventricular Dysplasia to Chromosome 3p23 Circulation, December 22, 1998; 98(25): 2791 - 2795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Matsuo, T. Nishikimi, C. Yutani, T. Kurita, W. Shimizu, A. Taguchi, K. Suyama, N. Aihara, S. Kamakura, K. Kangawa, et al. Diagnostic Value of Plasma Levels of Brain Natriuretic Peptide in Arrhythmogenic Right Ventricular Dysplasia Circulation, December 1, 1998; 98(22): 2433 - 2440. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||